NCT05786196招募中不适用
Multicenter Glaucoma Study Investigating Standalone Canaloplasty, Randomized Controlled Trial: iTrack Advance (Nova Eye, Inc.) Compared to OMNI (Sight Sciences)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 86
- 试验地点
- 5
- 主要终点
- The mean change in unmedicated Intraocular pressure (IOP) at Month-12 compared to baseline
研究概览
简要总结
A multicenter, randomized, clinical trial to evaluate the efficacy of canaloplasty performed as a standalone procedure using the iTrack™ Advance canaloplasty device (Nova Eye, Inc.) as compared to the OMNI® Surgical System (Sight Sciences) in patients with mild to moderate primary open-angle glaucoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 22 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female subjects, 22 years or older at the time of surgery
- •Diagnosed with mild to moderate primary open angle glaucoma
- •Candidate for canaloplasty surgery: i.e., catheterization of Schlemm's canal and subsequent viscodilation of Schlemm's canal, without trabeculotomy
- •Intolerance to medical therapy OR need/willingness to reduce medications
- •At the Screening Visit, IOP of ≤ 30 mmHg while on 1-4 ocular hypotensive medications
- •At the Baseline Visit, unmedicated IOP ≥ 21mmHg and ≤ 36 mmHg, and ≥ 3mmHg higher than medicated IOP
- •Shaffer grade of ≥ 3 in all four quadrants
- •Central corneal thickness ≥ 480µm and ≤ 620 µm
- •Able and willing to comply with the study procedures and attend all follow-up visits
- •Understands and signs the informed consent
排除标准
- •Any of the following prior treatments for glaucoma (study eye):
- •Laser trabeculoplasty
- •i. Selective Laser Trabeculoplasty (SLT) conducted within 6-months of the Screening Visit ii. Prior Argon Laser Trabeculoplasty
- •iStent or iStent Inject within 180 days of the Screening Visit
- •Endocyclophotocoagulation (ECP) or Micropulse laser
- •Trabeculectomy or other bleb forming procedure including Xen, Express, and glaucoma draining device/valve
- •Prior canaloplasty (ab interno and ab externo)
- •Prior goniotomy, or trabeculotomy (ab externo and ab interno)
- •Hydrus microstent
- •Suprachoroidal stent (e.g., Cypass, iStent Supra, MINIject)
- •Concurrent IOP-lowering procedure other than use of the iTrack Advance canaloplasty device OR the OMNI Surgical System at the time of surgery (e.g., ECP, CPC, etc.)
- •Acute angle closure, traumatic, congenital, malignant, uveitic or neovascular glaucoma, pigmentary glaucoma or pseudoexfoliative glaucoma
- •Cataract surgery within 6 months of the Screening Visit in the study eye
- •History of fellow eye with cataract surgery within 30 days of Screening
- •Subjects at significant risk by a washout of ocular hypotensive medication, and/or subjects where the unmedicated IOP is expected to exceed the upper limit of 36 mmHg
- •Use of systemic medications (either current, within 30 calendar days of Screening exam, or anticipated) that may cause an increase in IOP, (e.g., systemic steroids including inhaled and oral steroids used on a regular basis)
- •Ocular and/or systemic diseases that could affect the corneal endothelium (such as corneal endothelial dystrophy, intraocular inflammation and infection, or congenital abnormalities)
- •History of penetrating keratoplasty or another corneal transplant
- •BCVA of 20/200 or worse in the fellow eye not due to cataract
- •Previous treatment with OMNI or iTrack (Note: permitted if fellow eye only was treated)
- •BCVA of 20/50 or worse in the study eye not due to posterior capsular opacification
结局指标
主要结局
The mean change in unmedicated Intraocular pressure (IOP) at Month-12 compared to baseline
时间窗: 12 months
IOP will be measured at each visit with Goldmann applanation tonometry
Percentage of eyes achieving a 20% or greater reduction in unmedicated Intraocular pressure (IOP) at Month-12 compared to baseline and without any other intervention (medication or secondary surgery)
时间窗: 12 months
IOP will be measured at each visit with Goldmann applanation tonometry
次要结局
未报告次要终点
研究者
研究点 (5)
Loading locations...
相似试验
终止
不适用
Multicenter Ab-interno Glaucoma Study Investigating CanaloplastyPrimary Open Angle GlaucomaNCT04769453Nova Eye, Inc.20
尚未招募
不适用
Myopia Prevention Through Monitoring and Motivating Outdoor Activities With SmartwatchesMyopia, ProgressiveNCT05760911Shanghai Eye Disease Prevention and Treatment Center1,200
Unknown
3 期
Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma DropsMGD-Meibomian Gland DysfunctionDry EyeNCT03515187Shenzhen Hospital of Southern Medical University160
尚未招募
不适用
Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle GlaucomaNCT05696561New World Medical, Inc.100
尚未招募
不适用
Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle GlaucomaGlaucomaNCT05892185Mingche Biotechnology CO., LTD20